Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction

NCT01025154 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Clofarabine
DRUG: Idarubicin
DRUG: Cytarabine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]